Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones06-18

DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ shed 1.11% to $607.93 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,420.10 and Dow Jones Industrial Average falling 0.98% to 51,492.55.

This was the stock's second consecutive day of losses.

Regeneron Pharmaceuticals Inc. closed 25.96% short of its 52-week high of $821.11, which the company reached on January 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ fell 1.78% to $341.66, Moderna Inc. (MRNA) rose 11.55% to $61.80, and Gilead Sciences Inc. (GILD) fell 1.40% to $125.45.

Trading volume (1.3 M) eclipsed its 50-day average volume of 955,366.

Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

June 17, 2026 16:46 ET (20:46 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2644721050?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 04:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644721050","market":"sg","top_or_hot":-1,"title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a> shed 1.11% to $607.93 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index  falling 1.21% to 7,420.10 and Dow Jones Industrial Average  falling 0.98% to 51,492.55. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 25.96% short of its 52-week high of $821.11, which the company reached on January 9th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> fell 1.78% to $341.66, <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> Inc. (MRNA) rose 11.55% to $61.80, and <a href=\"https://laohu8.com/S/GILD\">Gilead</a> Sciences Inc. (GILD) fell 1.40% to $125.45. \n</p>\n<p>\n     Trading volume (1.3 M) eclipsed its 50-day average volume of 955,366. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 17, 2026 16:46 ET (20:46 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-18 04:46</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a> shed 1.11% to $607.93 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index  falling 1.21% to 7,420.10 and Dow Jones Industrial Average  falling 0.98% to 51,492.55. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 25.96% short of its 52-week high of $821.11, which the company reached on January 9th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> fell 1.78% to $341.66, <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> Inc. (MRNA) rose 11.55% to $61.80, and <a href=\"https://laohu8.com/S/GILD\">Gilead</a> Sciences Inc. (GILD) fell 1.40% to $125.45. \n</p>\n<p>\n     Trading volume (1.3 M) eclipsed its 50-day average volume of 955,366. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 17, 2026 16:46 ET (20:46 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2644721050","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2644721050","pubTimestamp":1781729160,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  shed 1.11% to $607.93 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.21% to 7,420.10 and Dow Jones Industrial Average  falling 0.98% to 51,492.55.This was the stock's second consecutive day of losses.Regeneron Pharmaceuticals Inc. closed 25.96% short of its 52-week high of $821.11, which the company reached on January 9th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc.  fell 1.78% to $341.66, Moderna Inc.  rose 11.55% to $61.80, and Gilead Sciences Inc.  fell 1.40% to $125.45.Trading volume  eclipsed its 50-day average volume of 955,366.Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published ind","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"尽管当天下跌，再生元制药公司股票的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1.5},"content_text":"DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ shed 1.11% to $607.93 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.21% to 7,420.10 and Dow Jones Industrial Average  falling 0.98% to 51,492.55. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Regeneron Pharmaceuticals Inc. closed 25.96% short of its 52-week high of $821.11, which the company reached on January 9th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ fell 1.78% to $341.66, Moderna Inc. (MRNA) rose 11.55% to $61.80, and Gilead Sciences Inc. (GILD) fell 1.40% to $125.45. \n\n\n     Trading volume (1.3 M) eclipsed its 50-day average volume of 955,366. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 17, 2026 16:46 ET (20:46 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644721050","isCrawlerRequest":true}